Avivavir has been approved by the Russian Ministry of Health as the first domestic drug to treat people with the emerging coronavirus, according to a new clause in the national drug registry.
Moscow – Sputnik. The property was developed by the Russian Direct Investment Fund and Khimrar, a Russian pharmaceutical investment company.
Sputnik. Vitaly Belousov
Moscow, the epicenter of the epidemic in Russia, recorded 69 new deaths during the last day of the Covid-19 epidemic, raising the total in the capital to 2477, according to the Crisis Response Center.
The fund’s supervisory board agreed last week to establish a joint company with the Khimrar group of companies to produce the drug “faviririrar,” which, according to Chinese experts, has proven effective in combating the Corona virus, as well as the production of other innovative antivirals, including those based on “faviririrar.” “.
The head of the Russian Center for Virology and Biotechnology “Viktor” announced that the center intends to start clinical trials of the emerging corona virus vaccine at the end of June and early July, indicating that these experiments are expected to be completed in September.